PubMed چکیده/رکورد

Matrix-dependent HHV-8 DNA detection in paired buffy coat and plasma from patients with hematological diseases in the Brazilian Amazon.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: HHV-8 is a lymphotropic oncogenic virus associated with Kaposi sarcoma and lymphoproliferative disorders. In the Western Brazilian Amazon, limited molecular data may underestimate its circulation, particularly when detection relies on one biological matrix. OBJECTIVES: To estimate HHV-8 molecular prevalence and compare viral DNA detection in paired buffy coat and plasma samples from patients with hematological diseases, METHODS: Paired buffy coat and plasma samples from 350 patients receiving care at a reference hematology center in the Western Brazilian Amazon were tested using qualitative nested PCR targeting HHV-8 ORF26. Demographic and diagnosis-related information was collected. Detection frequencies, prevalence ratios, and paired-matrix agreement metrics were estimated. RESULTS: HHV-8 DNA was detected in at least one matrix in 19/350 patients (5.43%; 95% CI: 3.50-8.32). Results were discordant in 18/19 positive participants: nine were positive only in buffy coat, nine only in plasma, and one in both matrices. Each matrix alone identified 10 participants, whereas paired testing identified 19. No statistically significant associations were identified with sex, age group, or hematological disease group. Agreement between matrices was low, with Cohen's kappa of 0.074 and positive agreement of 10.00%, indicating that buffy coat and plasma provided complementary rather than interchangeable qualitative PCR results. CONCLUSIONS: Buffy coat and plasma yielded largely non-overlapping qualitative HHV-8 PCR detections. Paired testing increased detections from 10 with either matrix alone to 19 when both were considered. These findings support matrix-informed surveillance in hematological populations from endemic or underrepresented settings.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

HHV-8Hematological diseasesMolecular prevalencePaired samplesWestern Brazilian Amazon
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Clinical Flow Cytometric Testing in Chronic Lymphocytic Leukemia.

Flow cytometry is the cornerstone for establishing the diagnosis of chronic lymphocytic leukemia (CLL), owing to its characteristic and well-defined immunophenotype that enables accurate distinction from other leukemias and lymphomas. Beyond diagnosis, flow cytometry provides essential prognostic information and allows sensitive detection of minimal residual disease (MRD), a strong predictor of clinical outcome. CLL MRD assessment is i…

PubMed2027

Flow Cytometric Immunophenotyping of Acute Lymphoblastic Leukemia.

Immunophenotyping by flow cytometry is an important component in the diagnostic evaluation of patients with acute lymphoblastic leukemia. This technique further permits the detection of minimal residual disease after therapy, a robust prognostic factor that may guide individualized treatment. We describe here laboratory methods for both the initial characterization of lymphoblasts at diagnosis and the detection of rare leukemic lymphob…

PubMed2027

Immunophenotyping of Acute Myeloid Leukemia.

Immunophenotyping by multiparameter flow cytometry is a rapid and efficient technique to simultaneously assess and correlate multiple individual cell properties like size and internal complexity along with antigen expression in a population of cells. This method is utilized for rapid characterization of the blasts and classification of acute myeloid leukemia (AML) in both the peripheral blood (PB) and bone marrow (BM). This technique i…

PubMed2027

Measurable Residual Disease.

Measurable residual disease (MRD) serves as a critical biomarker of prognosis, treatment efficacy, and clinical outcome. It captures the presence of residual tumor cells below the detection threshold of conventional microscopy. Multiparametric flow cytometry (MFC) offers a rapid, cost-efficient, and widely applicable platform for MRD detection through leukemia-associated immunophenotypes (LAIPs) and deviation-from-normal (DfN) antigen …